Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Spatially Resolved Transcriptome Landscape during Thyroid Cancer Progression

ABSTRACT: A Spatially Resolved Transcriptome Landscape during Thyroid Cancer Progression

PROVIDER: PRJNA1054236 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27277600_1.fastq.gz	Fastqsanger.gz
	SRR27277600_2.fastq.gz	Fastqsanger.gz
	SRR27277601_1.fastq.gz	Fastqsanger.gz
	SRR27277601_2.fastq.gz	Fastqsanger.gz
	SRR27277602_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 104

Similar Datasets

A Spatially Resolved Transcriptome Landscape during Thyroid Cancer Progression

Project description:Thyroid cancer ranks as the ninth most common cancer type in terms of incidence worldwide. Furthermore, the global incidence of thyroid cancer has been on the rise over the past decades.Spatial transcriptomics technology systematically profiles gene expression across tissue space by combing high-throughput RNA sequencing and imaging techniques. The applications of ST have revealed high-resolution spatial architecture and cellular crosstalk in many tumor types, advancing the discovery of new targets for diagnosis and therapy. However, the spatial architecture in thyroid cancer and the structural differences in the TME among papillary thyroid cancer (PTC), locally advanced thyroid cancer (LPTC), and Anaplastic thyroid carcinoma (ATC) have been little investigated. Herein , we applied ST and scRNA-seq data to reveal the spatial difference of TME in PTC, LPTC, and ATC samples.

2025-02-16 | GSE250521 | GEO

A spatially resolved transcriptome landscape during thyroid cancer progression.

Project description: Not available

| S-EPMC12047530 | biostudies-literature

Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Project description:Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

| PRJNA1403500 | ENA

Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma

Project description:Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma

| PRJNA1336716 | ENA

Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma II

Project description:Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma II

| PRJNA1336837 | ENA

Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Project description:Pancreatic ductal adenocarcinoma (PDAC) exhibits profound molecular heterogeneity and poor prognosis, necessitating novel tailored therapies. The basal and classical subtypes - driven by glycolysis versus lipid metabolism - have distinct prognostic implications. We mapped PDAC molecular subtype heterogeneity, capturing spatially-resolved gene expression signatures and generating a comprehensive high-resolution dataset of 42,035 spatial spots. Subtype assignments were validated via multiplex immunofluorescence and quantitative analyses in patient-derived organoids. Our analysis resolved cancer cell signatures, deconvoluted intra-tumoral heterogeneity, and delineated a classical-to-basal trajectory. We identified metabolically ‘hot’, high-grade tumor niches characterized by concurrent enrichment of glycolysis and lipogenesis across both subtypes, nominating them as subtype-agnostic therapeutic targets. Preclinical models demonstrated that despite the basal subtype’s glycolysis dependence, both classical and basal tumors are susceptible to glycolysis inhibition. This work challenges the dogma of subtype-specific therapeutic silos and demonstrates highly adaptable energetic niches as reservoirs to drive tumor progression.

2026-04-22 | GSE316631 | GEO

Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma

2026-04-22 | GSE309669 | GEO

Spatially resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma II

2026-04-22 | GSE309739 | GEO

Spatially resolved integrative analysis of transcriptomic and metabolomic changes in tissue injury studies

Project description:<p>Recent developments in spatially resolved -omics have enabled the joint study of gene expression, metabolite levels and tissue morphology, offering greater insights into biological pathways. Integrating these modalities from matched tissue sections to probe spatially-coordinated processes, however, remains challenging. Here we introduce MAGPIE, a framework for co-registering spatially resolved transcriptomics, metabolomics, and tissue morphology from the same or consecutive sections. We show MAGPIE’s generalisability and scalability on spatial multi-omics data from multiple tissues, combining Visium with MALDI and DESI mass spectrometry imaging. MAGPIE was also applied to new multimodal datasets generated with a specialised sampling strategy to characterise the metabolic and transcriptomic landscape in an in vivo model of drug-induced pulmonary fibrosis and to link small-molecule co-detection with endogenous lung responses. MAGPIE demonstrates the refined resolution and enhanced interpretability that spatial multimodal analyses provide for studying tissue injury especially in pharmacological contexts, and delivers a modular, accessible workflow for data integration</p>

2025-12-03 | MTBLS13445 | MetaboLights

Spatially resolved epigenomic profiling of single cells in complex tissues

Project description:The recent development of spatial omics enables single-cell profiling of the transcriptome and the 3D organization of the genome in a spatially resolved manner. A spatial epigenomics method would expand the repertoire of spatial omics tools and accelerate our understanding of the spatial regulation of cellular processes and tissue functions. Here, we developed an imaging approach for spatially resolved profiling of epigenetic modifications in single cells

2022-12-16 | GSE191069 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data